GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China National Accord Medicines Corp Ltd (SZSE:000028) » Definitions » FCF Yield %

China National Accord Medicines (SZSE:000028) FCF Yield % : 8.96 (As of May. 27, 2024)


View and export this data going back to 1993. Start your Free Trial

What is China National Accord Medicines FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, China National Accord Medicines's Trailing 12-Month Free Cash Flow is ¥1,769 Mil, and Market Cap is ¥19,748 Mil. Therefore, China National Accord Medicines's FCF Yield % for today is 8.96%.

The historical rank and industry rank for China National Accord Medicines's FCF Yield % or its related term are showing as below:

SZSE:000028' s FCF Yield % Range Over the Past 10 Years
Min: -6.63   Med: 5.47   Max: 16.74
Current: 8.96


During the past 13 years, the highest FCF Yield % of China National Accord Medicines was 16.74%. The lowest was -6.63%. And the median was 5.47%.

SZSE:000028's FCF Yield % is ranked better than
72.92% of 96 companies
in the Medical Distribution industry
Industry Median: 2.695 vs SZSE:000028: 8.96

China National Accord Medicines's FCF Margin % for the quarter that ended in Mar. 2024 was -3.70%.


China National Accord Medicines FCF Yield % Historical Data

The historical data trend for China National Accord Medicines's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China National Accord Medicines FCF Yield % Chart

China National Accord Medicines Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.07 6.17 8.11 15.90 16.21

China National Accord Medicines Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.96 19.64 -2.06 34.06 -16.52

Competitive Comparison of China National Accord Medicines's FCF Yield %

For the Medical Distribution subindustry, China National Accord Medicines's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China National Accord Medicines's FCF Yield % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, China National Accord Medicines's FCF Yield % distribution charts can be found below:

* The bar in red indicates where China National Accord Medicines's FCF Yield % falls into.



China National Accord Medicines FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

China National Accord Medicines's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=2614.931 / 16134.81935
=16.21%

China National Accord Medicines's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-706.051 * 4 / 17097.6768
=-16.52%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China National Accord Medicines FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


China National Accord Medicines FCF Yield % Related Terms

Thank you for viewing the detailed overview of China National Accord Medicines's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


China National Accord Medicines (SZSE:000028) Business Description

Traded in Other Exchanges
Address
No. 15, Ba Gua Si 4th Road, Accord Pharmaceutical Building, Futian District, Guangdong Province, Shenzhen, CHN, 518029
China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.
Executives
Su Wei Wei Independent director
Chen Chang Bing Secretary Dong
Peng Juan Director
Fu Ming Zhong Director

China National Accord Medicines (SZSE:000028) Headlines

No Headlines